
CureVac COVID Vaccine Letdown Spotlights mRNA Design Challenges
Scientists are searching for explanations to disappointing final-stage trial results. These insights could help guide the future development of mRNA vaccines
Scientists are searching for explanations to disappointing final-stage trial results. These insights could help guide the future development of mRNA vaccines
Creators on social media platforms significantly extend the reach of coronavirus and vaccine information
The risk of infection increased by up to 30 percent or so among people with observances in the first 10 months of 2020
Genomic sequencing efforts are limited in developing countries, but scientists are mobilizing to help
Pandemic highlights for the past two weeks
Today we bring you a new episode in our podcast series: COVID, Quickly. Every two weeks, Scientific American ’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between.You can listen to all past episodes here...
The pandemic is teaching us key lessons about how people respond to crisis and misinformation, and it is spurring changes in the way scientists study public health questions
Doling out cash rewards and lifting mask mandates could increase vaccine uptake, some research suggests
The new rules would require employers to notify workers of possible exposure to the disease and to report deaths or hospitalizations to the government
The international collaboration does not have enough COVID vaccine doses to meet its goals, so wealthy countries must step up to fill the gap
An examination of the arguments that SARS-CoV-2 escaped from a lab in China and the science behind them
Viruses that “spill over” to people do not stick around in animals, so finding true sources takes years of careful work, an expert says
A pan-coronavirus vaccine could be “one vaccine to rule them all,” and so far it has shown strong results in mice, hamsters, monkeys, horses and even sharks.
Large gatherings and much more lenient restrictions have allowed the virus to spread at devastating levels
Every two weeks, Scientific American ’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between...
Pandemic highlights for the past two weeks
Today we bring you a new episode in our podcast series: COVID, Quickly. Every two weeks, Scientific American ’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between...
A detailed analysis suggests that COVID deaths and other pandemic-related mortality may have been significantly undercounted in the rural South and West
At a mass vaccination site in New Jersey, people got a shot of hope
Standard treatments such as steroids, as well as illnesses such as diabetes, make the fungal infection worse
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account